Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure

Circulation Research

Volumn 78, Issue 1, 1996, Pages 58-64

  Smith, Carolyn J ^a   Sun, Dong ^a   Hoegler, Carl ^a   Roth, Barrie S ^a   Zhang, Xiaoping ^a   Zhao, Gong ^a   Xu, Xiao Bin ^a   Kobari, Yukage ^a   Pritchard Jr , Kirkwood ^a   Sessa, William C ^b   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cyclooxygenase; endothelial cell NO synthase; GAPDH; Northern blots; von Willebrand factor

Indexed keywords

ACETYLCHOLINE; COMPLEMENTARY DNA; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY DILATATION; DOG; ENZYME ASSAY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; NONHUMAN; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

EID: 9044242645     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.58     Document Type: Article

References (35)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-142.
2. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596-1601.
3. Kaiser L, Spickard RC, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol. 1989;256:H962-H967.
4. Wang J, Seyedi N, Xu X, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
5. Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation. 1993;88:55-61.
6. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, St John Sutton MG, Selwyn AP, Alexander RW, Ganz P. Endothelium-dependent dilation of coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81:772-779.
7. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR. Endothelial dysfunction in chronic heart failure: experimental and clinical studies. Arzneimittelforschung. 1994;44(suppl I):455-458.
8. Busse R, Hecker M, Fleming I. Control of nitric oxide and prostacvclin synthesis in endothelial cells. Arzneimittelforschung. 1994; 44(suppl I):392-396.
9. Sessa WC, Harrison JK, Luthin DR, Pollock JS, Lynch KR. Genomic analysis and tissue expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension. 1993;21:934-938.
10. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 1992;267:15274-15276.
11. Wang J, Zhao G, Shen W, Ochoa M, Moore D, Hubbard JW, Hintze TH. Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failure. J Cardiovasc Pharmacol. 1993;22(suppl 7):S51-S58.
12. Belloni FL, Wang J, Hintze TH. Adenosine causes bradycardia in pacing-induced heart failure. Circulation. 1992;85:1118-1124.
13. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
14. Liu J, Sessa WC. Identification of covalently bound amino-terminal myristic acid in endothelial nitric oxide synthase. J Biol Chem. 1994; 269:11691-11694.
15. Smith CJ, Morrow JD, Roberts LJ II, Marnett LJ. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun. 1993;192:787-793.
16. Inase N, Levine TM, Lazarus SC. Mitogen-inducible prostaglandin G/H synthase is expressed in canine mastocytoma cells. Am J Respir Cell Mol Biol. 1993;9:526-532.
17. Pritchard KA Jr, O'Banion MK, Miano JM, Vlasic N, Bhatia UG, Young DA, Stemerman MB. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem. 1994; 269:8504-8509.
18. Szoke E, Zhang X, Wang J, Anversa P, Hintze TH. Myocardial fibrosis and chronic tachycardia induced heart failure in dogs. Circulation. 1993;88(suppl I):I-541. Abstract.
19. Shannon RP, Komamura K, Stambler BS, Bigaud M, Manders WT, Vatner SF. Alterations in myocardial contractility in conscious dogs with cardiomyopathy. Am J Physiol. 1991;260:H1903-H1911.
20. Mason DT, Zelis R, Amsterdam EA. Action of nitrites on the peripheral circulation and myocardial oxygen consumption: significance in the relief of angina pectoris. Chest. 1971;59:296-305.
21. Hintze TH, Vatner SF. Comparison of the effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs. Circ Res. 1983;52(suppl 1):139-146.
22. Hintze TH, Wang J, Seyedi N, Wolin MS. Role of EDRF/NO in chronic high coronary blood flow states during myocardial dysfunction and failure. In: Bevan J, Kaley G, Rubanyi G, eds. Flow Velocity Control of the Circulation. New York, NY: Oxford University Press: 1995.
23. O'Murchu B, Miller VM, Perella MA, Burnett JC. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 1994;93:165-171.
24. Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze TH. Selective impairment of vagally mediated nitric-oxide-dependent coronary vasodilation in conscious dogs after pacing induced heart failure. Circulation. 1995;91:2655-2663.
25. Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 1994;89:375-384.
26. Rubanyi G, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250: H1145-H1149.
27. Awobsi MA, Widmath MD, Sessa WC, Sumpio BE. Cyclic strain increases endothelial nitric oxide synthase activity. Surgery. 1994; 116:439-445.
28. Holtz J, Goetz RM. The endothelium and the renin-angiotensin system. Arzneimittelforschung. 1994;44(suppl I):397-402.
29. Pilz RB, Sushasini M, Idriss S, Meinkoth JL, Boss GR. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 1995;9:552-558.
30. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res. 1993;73:808-812.
31. Brady AJB, Poole-Wilson PA, Harding SE, Pickering T. Nitric oxide production within cardiac myocytes reduced their contractility in endotoxemia. Am J Physiol. 1993;265:H176-H182.
32. Balligand JL, Ungureanu D, Kelly RA, Smith T. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage conditioned medium. J. Clin Invest. 1993;91:2314-2319.
33. Levine B, Kalman J, Meyer L, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
34. Winlaw DS, Smythe GA, Keogh AM, Schyvwens AG, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet. 1994;344:373-374.
35. Kichuk MR, Seyedi N, Marboe C, Addonizio L, Michler R, Hintze TH. Reduced EDRF production from coronary microvessels from the failing explanted human heart. FASEB J. 1994;8:A826.